QQ客服 官方微博 反馈留言

	Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention
	Bai, Xiao-Fang; Zhang, Ya-Ping; Zhou, Juan; Wu, Yue; Li, Rui-Feng; Sun, Li-Zhe; Ma, Qiang-Qiang; Lou, Bo-Wen; Zhai, Bo-Wen; Liu, Meng-Ping
刊名	THROMBOSIS RESEARCH
	2018
卷号	170页码:142-147
关键词	Prognosis Risk factor GRACE score CYP2C19 metabolizer Acute coronary syndrome
ISSN号	0049-3848
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2830217
专题	西安交通大学
推荐引用方式 GB/T 7714	Bai, Xiao-Fang,Zhang, Ya-Ping,Zhou, Juan,et al. Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention[J]. THROMBOSIS RESEARCH,2018,170:142-147.
APA	Bai, Xiao-Fang.,Zhang, Ya-Ping.,Zhou, Juan.,Wu, Yue.,Li, Rui-Feng.,...&Yuan, Zu-Yi.(2018).Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention.THROMBOSIS RESEARCH,170,142-147.
MLA	Bai, Xiao-Fang,et al."Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention".THROMBOSIS RESEARCH 170(2018):142-147.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。